The World Health Organization has labelled the current COVID-19 outbreak a worldwide public health emergency of international significance (WHO). The latest data on 7.86 L cases and 5,30,740 death records globally (until February 1, 2023) illustrate the severity of this viral illness. According to WHO estimates through February 1st 2023, COVID-19 infection is a pandemic, surfaceto- surface infectious illness with a case fatality rate of 1.2%. The only options available to combat COVID-19 are vaccination and the implementation of an efficient preventative strategy. Also, a retrospective examination offers data that raises the question of how crucially important preventative efforts were in containing the 2003 SARS outbreak. The potency of surface disinfectants, the makeup of hand sanitizer, and the right material used to create personal protective equipment are all essential components of preventative measures’ efficacy (PPE). During COVID-19, antiviral medications, corticosteroids, vaccinations, and monoclonal antibodies were some of the frequently utilised treatments. Increasing testing and contact tracing, expanding virtual healthcare services, investing in vaccination distribution and administration, and providing mental health support and resources are some of the common post-COVID-19 actions. This article clarifies the numerous preventative actions, such as choosing the right surface cleaners, performing the proper hand sanitization, and empowering PPE that may be a viable intervention to combat COVID-19.
COVID-19 Infection; Antiviral Medications; Corticosteroids, Vaccinations; and Monoclonal Antibodies